ERIC DOBMEIER
CIK 1202785 · President, CEO · last filed 2026-06-11
ERIC DOBMEIER is a President, CEO who has filed 126 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for JBIO, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$38.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.03M
9
126
-$38.16M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JBIO | Director | — | $15.34 | — | $0 | 2 | 2026-06-11 |
| GPCR | Director | — | $42.93 | — | $0 | 2 | 2025-06-25 |
| JANX | Director | 9,981 | $13.56 | $135.3K | $0 | 3 | 2025-06-13 |
| ATRA | Director | 563,325 | $10.41 | $5.86M | $236.9K | 13 | 2023-11-14 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | President, CEO | 0 | $40.39 | $0 | -$1.79M | 22 | 2023-08-11 |
| ADPT | Director | 1,504 | $17.60 | $26.5K | -$2.70M | 12 | 2021-02-17 |
| Aravive, Inc. (VSAR) Delisted | Director | 18,160 | — | — | $0 | 2 | 2017-12-22 |
| Seagen Inc. (SGEN) Delisted | Chief Operating Officer | 117,424 | $228.74 | $26.86M | -$33.92M | 66 | 2017-12-06 |
| STEMLINE THERAPEUTICS INC (STML) Delisted | Director | 27,963 | — | — | $0 | 4 | 2017-06-20 |
Recent Filings
126 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | JBIO | Grant (A) | — | $0 | EDGAR |
| 2025-06-25 | GPCR | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | JANX | Grant (A) | +3,750 | $0 | EDGAR |
| 2025-05-01 | JBIO | Grant (A) | — | $0 | EDGAR |
| 2024-07-24 | JANX | Grant (A) | +1,231 | $0 | EDGAR |
| 2024-07-22 | JANX | Grant (A) | +7,500 | $0 | EDGAR |
| 2024-06-27 | GPCR | Grant (A) | — | $0 | EDGAR |
| 2023-11-14 | ATRA | Buy (P) | +446,825 | $101.3K | EDGAR |
| 2023-08-11 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Disp (D) | −301,138 | $0 | EDGAR |
| 2023-06-02 | ATRA | Grant (A) | +57,000 | $0 | EDGAR |